je.st
news
U.S. regulators reject Sanofi's MS treatment Lemtrada
2014-01-01 22:27:11| Biotech - Topix.net
Sanofi's Lemtrada multiple sclerosis treatment has failed to win approval from U.S. regulators, dealing a setback to a drug which was at the heart of the French drugmaker's $20 billion takeover of biotech firm Genzyme.
Tags: treatment
reject
regulators
sanofis
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|
||||||||||||||||||||